Last Updated: August 10, 2026

Novel Labs Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NOVEL LABS INC

NOVEL LABS INC has fifty-six approved drugs.

There are three tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc

US Patents:	0
Tradenames:	42
Ingredients:	41
NDAs:	56

Drugs and US Patents for Novel Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novel Labs Inc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	SOLUTION;ORAL	204603-001	Apr 29, 2015		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	POTASSIUM CHLORIDE	potassium chloride	CAPSULE, EXTENDED RELEASE;ORAL	204828-002	Aug 16, 2016	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	FLUCYTOSINE	flucytosine	CAPSULE;ORAL	204652-001	Jul 7, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	204021-004	Jun 12, 2017		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	FAMOTIDINE	famotidine	FOR SUSPENSION;ORAL	201695-001	Dec 17, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	LINEZOLID	linezolid	TABLET;ORAL	207526-001	Aug 22, 2016	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Novel Labs Inc	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET;SUBLINGUAL	204299-001	Jun 3, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.